Invention Grant
![Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide](/docs/US/2023-07-04/US11691977B2/abs.jpg.600x600.jpg)
- Patent Title: Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide
-
Application No.: US17075091Application Date: 2020-10-20
-
Publication No.: US11691977B2Publication Date: 2023-07-04
- Inventor: Christoph Hoenke , Barbara Bertani , Marco Ferrara , Giacomo Fossati , Sara Frattini , Riccardo Giovannini , Scott Hobson
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent David L. Kershner
- Priority: EP 189600 2015.10.13
- The original application number of the division: US15865695 2018.01.09
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519
![Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide](/abs-image/US/2023/07/04/US11691977B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.
Public/Granted literature
- US20210032259A1 CYCLIC ETHER DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYAMIDE Public/Granted day:2021-02-04
Information query
